A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
Abstract
The 21-gene assay Oncotype DX (21-GA) shows promise as a guide in deciding when to initiate adjuvant chemotherapy in women with hormone receptor-positive early-stage breast cancer. Nevertheless, its routine use remains controversial, owing to insufficient evidence of its clinical utility and cost-effectiveness. Accordingly, we aim to quantify the value of conducting further research to reduce decision uncertainty in the use of the 21-GA.Using...
Paper Details
Title
A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
Published Date
Oct 1, 2019
Journal
Volume
22
Issue
10
Pages
1102 - 1110
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History